Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Matrix-type fentanyl patch impact on immunotherapy efficacy in cancer pain
ChiCTR2600132776Phase 4Completed
- Sponsor
- Xuzhou Central Hospital
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fentanyl in cancer pain (3 arms), sponsored by Xuzhou Central Hospital. Primary endpoints: Cytokine profiling and Lymphocyte subsets. Started May 2025; status: completed.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2600132776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132776.